Teligene

Teligene (Suzhou Teligene Biotechnology Co., Ltd.) is a clinical-stage biopharmaceutical company founded in 2011 in Suzhou, China by Dr. Zhang Dawei, a former chief scientist at Amgen. The company focuses on the design, research and industrialization of innovative small-molecule targeted drugs for oncology, with a pipeline addressing lung cancer, breast cancer, and head and neck squamous cell carcinoma. Teligene US LLC is a wholly owned US subsidiary advancing these candidates through clinical development. It was surfaced as a portfolio company of idg-capital and added to the API Evangelist network for enrichment; as a drug-development biotech it publishes no public API, developer portal, or machine-readable API surface.

Teligene is profiled on the APIs.io network. Tagged areas include Company, Healthcare, Biotechnology, Pharmaceuticals, and Oncology.

🌐 Visit website 📡 Source on GitHub

5.7/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanyHealthcareBiotechnologyPharmaceuticalsOncologyDrug Discovery

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 5.7/100 · minimal

Contract Quality 0.0 / 25

Developer Ergonomics 0.0 / 20

Commercial Clarity 0.0 / 20

Operational Transparency 0.0 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/teligene: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Resources

Company 2

The organization behind the API

Website

Website

LinkedIn

Source (apis.yml)

aid: teligene
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/teligene.png
name: Teligene
description: Teligene (Suzhou Teligene Biotechnology Co., Ltd.) is a clinical-stage biopharmaceutical company founded in 2011
  in Suzhou, China by Dr. Zhang Dawei, a former chief scientist at Amgen. The company focuses on the design, research and
  industrialization of innovative small-molecule targeted drugs for oncology, with a pipeline addressing lung cancer, breast
  cancer, and head and neck squamous cell carcinoma. Teligene US LLC is a wholly owned US subsidiary advancing these candidates
  through clinical development. It was surfaced as a portfolio company of idg-capital and added to the API Evangelist network
  for enrichment; as a drug-development biotech it publishes no public API, developer portal, or machine-readable API surface.
url: https://raw.githubusercontent.com/api-evangelist/teligene/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- idg-capital
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-21'
tags:
- Company
- Healthcare
- Biotechnology
- Pharmaceuticals
- Oncology
- Drug Discovery
apis: []
common:
- type: Website
  url: https://www.teligenebio.cn/en/
- type: LinkedIn
  url: https://www.linkedin.com/company/teligene-us
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-21'
  status: nochange
  artifacts_added: 0
  pass: local-v1